Potential of neurotrophic factors in therapy of Parkinson’s disease

  • J. C. Möller
  • J. Sautter
  • A. Kupsch
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 48)


Neurotrophic factors of dopaminergic neurons may represent a potential neuroprotective therapy for PD. This article reviews published experiments that demonstrate the effects of neurotrophic factors on dopaminergic neurons in vitro and in vivo. At present this issue is predominantly investigated in basic neuroscientific research. Its possible future clinical relevance is discussed.


Nerve Growth Factor Neurotrophic Factor Dopaminergic Neuron Ciliary Neurotrophic Factor Trophic Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 89: 11347–11351PubMedCrossRefGoogle Scholar
  2. Altar CA, Boylan CB, Fritsche M, Jackson C, Hyman C, Lindsay RM (1994) The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp Neurol 130:31–40PubMedCrossRefGoogle Scholar
  3. Anderson DJ, Axel R (1986) A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and gluco-corticoids. Cell 47: 1079–1090PubMedCrossRefGoogle Scholar
  4. Araujo DM, Lapchak PA, Collier B, Chabot JG, Quirion R (1989) Insulin-like growth factor −1 (somatomedin C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res 484: 130–139PubMedCrossRefGoogle Scholar
  5. Beck KD, Kniisel B, Hefti F (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1–3)-Insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52: 855–866PubMedCrossRefGoogle Scholar
  6. Beck KD, Valverde J, Alexi T, Poulsen K, Moffet B, Vandlen RA, Rosenthal A, Hefti F (1995a) Mesencephalic dopaminergic neurons are protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339–341PubMedCrossRefGoogle Scholar
  7. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F (1995b) IGF-1 gene disruption results in reduced brain size, CNS hypomyelination and loss of hippocampal granule and striatal parvalbumin-containing cells. Neuron 14: 717–730PubMedCrossRefGoogle Scholar
  8. Engele J, Bohn MC (1991) The neurotrophic effects of fibroblast growth factor in vitro are mediated by mesencephalic microglia. J Neurosci 11: 3070–3078PubMedGoogle Scholar
  9. Ernfors P, Lee KF, Jaenisch R (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368: 147–150PubMedCrossRefGoogle Scholar
  10. Frautschy SA, Walicke PA, Baird A (1991) Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res 553: 291–299PubMedCrossRefGoogle Scholar
  11. Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridiniurn toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci USA 91: 5104–5108PubMedCrossRefGoogle Scholar
  12. Gall CM, Gold SJ, Isackson PJ, Seroogy KB (1992) Brain-derived neurotrophic factor and neurotrophin-J mRNAs are expressed in ventral midbrain regions containing dopaminergic regions. Mol Cell Neurosci 3: 56–63PubMedCrossRefGoogle Scholar
  13. Garcia E, Rios C, Sotelo J (1992) Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice. Neurochem Res 17: 979–982PubMedCrossRefGoogle Scholar
  14. Gomez-Pinilla F, Lee JWK, Cotman CW (1992) Basic FGF in the adult brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J Neurosci 12: 345–355PubMedGoogle Scholar
  15. Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH (1991) Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J Neurochem 57: 479–482PubMedCrossRefGoogle Scholar
  16. Hagg T, Varon S (1993) Ciliary neurotrophic factor (CNTF) prevents axotomy-induced degeneration of adult rat substantia nigra dopaminergic neurons. Proc Natl Acad Sci USA 90: 6315–6319PubMedCrossRefGoogle Scholar
  17. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE, Rosenthal A (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266: 1062–1066PubMedCrossRefGoogle Scholar
  18. Hoffer BJ, Hoffmann A, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin LFH, Gerhardt GA (1994) Glial cell line-derived neurotrophic factor reverses toxininduced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182: 107–111PubMedCrossRefGoogle Scholar
  19. Honegger P, Guentert-Lauber B (1983) Epidermal growth factor (EGF) stimulation of cultured brain cells. I. Enhancement of the developmental increase in glial enzymatic activity. Dev Brain Res 11: 245–251CrossRefGoogle Scholar
  20. Hudson J, Granholm AC, Gerhardt GA, Henry MA, Hoffmann A, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, Hoffer BJ (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425–432PubMedCrossRefGoogle Scholar
  21. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230–232PubMedCrossRefGoogle Scholar
  22. Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14: 335–347PubMedGoogle Scholar
  23. Iacovitti L (1991) Effects of a novel differentiation factor on the development of catecholamine traits in noncatecholamine neurons from various regions of the rat brain: studies in tissue culture. J Neurosci 11: 2403–2409PubMedGoogle Scholar
  24. Iacovitti L, Evinger MJ, Stull ND (1992) Muscle-derived differentiation factor increases expression of the tyrosine hydroxylase gene and enzyme activity in cultured dopamine neurons from the rat midbrain. Mol Brain Res 16: 215–222PubMedCrossRefGoogle Scholar
  25. Jin BK, Schneider JS, Du YY, Iacovitti L (1991) MDF, a muscle factor, produces partial motor recovery in 6-hydroxydopamine lesioned rats by increasing tyrosine hydroxylase activity and catechol levels. Soc Neurosci Abstr 18: 1296Google Scholar
  26. Knüsel B, Michel PP, Schwaber JS, Hefti F (1990) Selective and nonselective stimulation of central and cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Neurosci 10: 558–570PubMedGoogle Scholar
  27. Knüsel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88: 961–965PubMedCrossRefGoogle Scholar
  28. Knüsel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmer HR, Nikolics K, Hefti F (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12: 4391–4402PubMedGoogle Scholar
  29. Kordower JH, Fiandaca MS, Notter MFD, Hansen JT, Gash DM (1990) NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. J Neurosurg 73: 413–428Google Scholar
  30. Korsching S (1993) The neurotrophic factor concept: a reexamination. J Neurosci 13: 2739–2748PubMedGoogle Scholar
  31. Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K (1995) TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against toxicity. EMBO J 14: 736–742PubMedGoogle Scholar
  32. Leonard S, Luthman D, Logel J, Luthman J, Antle C, Freedman R, Hoffer B (1993) Acidic and basic fibroblast growth factor mRNAs are increased in striatum following MPTP-induced dopamine neurofiber lesion: assay by quantitative PCR. Mol Brain Res 18: 275–284PubMedCrossRefGoogle Scholar
  33. Leutz A, Schachner M (1981) Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures. Cell Tissue Res 220: 393–404PubMedCrossRefGoogle Scholar
  34. Lin LFH, Doherty J, Lile J, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130–1132PubMedCrossRefGoogle Scholar
  35. Lindner MD, Winn SR, Baetge EE, Hammang JP, Gentile FT, Doherty E, McDermott PE, Frydel B, Ullman MD, Schallert T, Emerich DF (1995) Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp Neurol 132: 62–76PubMedCrossRefGoogle Scholar
  36. Matsuda S, Saito H, Nishiyama N (1992) Basic fibroblast growth factor ameliorates rotational behavior of substantia nigra-transplanted rats with lesions of the dopaminergic nigrostriatal neurons. Jpn J Pharmacal 59: 365–370CrossRefGoogle Scholar
  37. Olson L, Backlund EO, Ebendal T, Freedman R, Hamberger B, Hansson P, Hoffer B, Lindblom U, Meyerson B, Stromberg I, Sydow O, Seiger A (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson’s disease. Arch Neurol 48: 373–381PubMedCrossRefGoogle Scholar
  38. Oppenheim RW, Houenou LJ, Johnson JE, Lin LFH, Li L, Lo AC, Newsome AL, Prevette DM, Wang S (1995) Developing motoneurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373: 344–346PubMedCrossRefGoogle Scholar
  39. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912–1921PubMedGoogle Scholar
  40. Otto D, Unsicker K (1992) Effects of FGF-2 on dopaminergic neurons. Neurosci Facts 3: 82–83Google Scholar
  41. Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A (1991) Intraventricular infusion of epidermal growth factor restores dopaminergic pathways in hemiparkinsonian rats. Mov Disord 6: 281–287PubMedCrossRefGoogle Scholar
  42. Poulsen KT, Armanini MP, Klein RD, Hynes MA, Phillips HS, Rosenthal A (1994) TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13: 1245–1252PubMedCrossRefGoogle Scholar
  43. Sauer H, Oertel WH (1994) Progressive degeneration of nigra striatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59: 401–415PubMedCrossRefGoogle Scholar
  44. Sauer H, Fischer W, Nikkah G, Wiegand P, Brundin P, Lindsay RM, Bjürklund A (1993) Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal ventral mesencephalic grafts. Brain Res 626: 37–44PubMedCrossRefGoogle Scholar
  45. Sauer H, Rosenblad C, Bjürklund A (1995) GDNF but not TGFβ3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopaminelesion. Proc Natl Acad Sci USA 92: 8935–8939PubMedCrossRefGoogle Scholar
  46. Sendtner M (1995) Neurotrophic factors for motoneurons. J Neurol 242, 1–2CrossRefGoogle Scholar
  47. Sendtner M, Kreutzberg GW, Thoenen H (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345: 440–441PubMedCrossRefGoogle Scholar
  48. Sendtner M, Schmalbruch H, Stockli KA, Caroll P, Kreutzberg GW, Thoenen H (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358: 502–504PubMedCrossRefGoogle Scholar
  49. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59: 99–106PubMedCrossRefGoogle Scholar
  50. Strömberg I, Herrera-Marschitz M, Ungerstedt U, Ebendal T, Olson L (1985) Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects on NGF on graft survival, fiber growth and rotational behaviour. Exp Brain Res 60: 335–349PubMedCrossRefGoogle Scholar
  51. Studer L, Spenger C, Seiler RW, Altar A, Lindsay RM, Hyman C (1995) Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur J Neurosci 7: 223–233PubMedCrossRefGoogle Scholar
  52. Tomac A, Lindquist E, Lin LFH, Ügren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335–339PubMedCrossRefGoogle Scholar
  53. Unsicker K, Grothe C, Westermann R, Wewetzer K (1992) Cytokines in neural regeneration. Curr Opin Neurobiol 2: 671–678PubMedCrossRefGoogle Scholar
  54. Wiegand SJ, Alexander C, Lindsay RM, Di Stefano PS (1991) Soc Neurosci Abstr 17: 1121Google Scholar
  55. Yan Q, Elliot J, Snider WD (1992) Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell daeth. Nature 360: 753–755PubMedCrossRefGoogle Scholar
  56. Yan Q, Matheson C, Lopez QT (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373: 341–344PubMedCrossRefGoogle Scholar
  57. Yoshida K, Gage F (1991) Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 538: 118–126PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1996

Authors and Affiliations

  • J. C. Möller
    • 1
  • J. Sautter
    • 1
  • A. Kupsch
    • 1
  1. 1.Department of NeurologyUniversity of MunichMunichGermany

Personalised recommendations